» Articles » PMID: 18565560

Epidemiology of Hepatitis B Virus Infection Among the Tribes of Andaman and Nicobar Islands, India

Overview
Date 2008 Jun 21
PMID 18565560
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The Andaman and Nicobar Islands, Union Territory of India, are home to six primitive tribes, namely the Great Andamanese, Onges, Jarawas and Sentinelese (Negrito race), and the Shompens and Nicobarese (Mongoloid race). These tribes account for about 8% of the island's population and the Nicobarese constitute >95% of the tribal population. Hepatitis B virus (HBV) infection is highly endemic among them with the prevalence of hepatitis B surface antigen (HBsAg) ranging from 23% among the Nicobarese to 66% among the Jarawas. The high HBsAg prevalence among pregnant mothers (20.5%), a linear increase in the age-specific rates of HBV exposure and the presence of HBsAg-positive individuals in every family suggested a combination of perinatal and horizontal transmission among the Nicobarese. Molecular studies of HBV isolates from the Onges, Nicobarese and Great Andamanese indicated a predominance of genotype D and there was a close similarity between these isolates and isolates from mainland India, suggesting that HBV may have been introduced from mainland India. In contrast, genotype C predominated among the Jarawas, with isolates similar to strains from Southeast Asian countries. Due to its high prevalence, hepatitis B vaccine is included in the childhood vaccination programme in these islands. It might be worth considering a pilot screening programme for chronic HBV patients to detect hepatocellular carcinoma.

Citing Articles

Assessing Hepatitis B virus infection, risk factors and immunization among particularly vulnerable tribal groups in Eastern India.

Bhattacharya H, Pattnaik M, Swain A, Padhi A, Rout U, Pradhan R Sci Rep. 2025; 15(1):8388.

PMID: 40069229 PMC: 11897223. DOI: 10.1038/s41598-025-91486-y.


Analyses of blood donor samples from eight provinces in Lao PDR suggest considerable variation concerning HBV exposure and carriage.

Nouanthong P, Hefele L, Keokhamphue J, Sorrasin V, Khounvisith V, Souksakhone C PLoS One. 2021; 16(12):e0259814.

PMID: 34898623 PMC: 8668104. DOI: 10.1371/journal.pone.0259814.


Testing for hepatitis in view of treatment: A universal health coverage service that can advance elimination of mother-to-child transmission of hepatitis B virus.

Hutin Y, Rewari B, Doherty M Indian J Med Res. 2020; 152(3):172-176.

PMID: 33107478 PMC: 7881814. DOI: 10.4103/ijmr.IJMR_2823_20.


Hepatitis B vaccination coverage across India: exploring the spatial heterogeneity and contextual determinants.

Khan J, Shil A, Mohanty S BMC Public Health. 2019; 19(1):1263.

PMID: 31510967 PMC: 6739912. DOI: 10.1186/s12889-019-7534-2.


Viral hepatitis: Indian scenario.

Satsangi S, Chawla Y Med J Armed Forces India. 2016; 72(3):204-10.

PMID: 27546957 PMC: 4982980. DOI: 10.1016/j.mjafi.2016.06.011.